YAP1 and squamous cell carcinoma: This was mainly attributed to the elevated proportion of cases with YAP1/WWTR1 genomic amplification and high expression heterogeneity of YAP/TAZ target gene signature, which correlated with decreased overall survival of patients with squamous cell cancers.